Search

OBJ signs research agreement with GlaxoSmithKline Healthcare

Pharmaceutical giant GlaxoSmithKline Consumer Healthcare has signed a short term arrangement with Leederville-based transdermal drug delivery company OBJ Ltd to carry out studies into the use of its technology on a range of nonprescription applications.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

OBJ (OBJ)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Source: Morningstar

Total Shareholder Return as at 31/07/19

1 year TSR5 year TSR
77thDroneShield76%
243rdResApp Health14%87%
327thNorwood Systems0%15%
627thOBJ-47%-29%
764thFamily Insights Group-67%0%
731 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/10/18
$24k Bought
15/05/18
$8k Bought
15/05/18
$9k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

116th↑OBJ$2.0m
131st↑Norwood Systems$1.3m
132nd↑Family Insights Group$1.2m
134th↑DroneShield$1.2m
136th↑ResApp Health$999k
198 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer